Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0UBASF
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Cirmtuzumab-ADC-7
|
|||||
| Synonyms |
Cirmtuzumab-ADC-7
Click to Show/Hide
|
|||||
| Organization |
VelosBio, Inc.; Merck & Co., Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Chronic lymphocytic leukemia [ICD11:2A82]
Clinical candidate
|
|||||
| Antibody Name |
Cirmtuzumab
|
Antibody Info | ||||
| Antigen Name |
Inactive tyrosine-protein kinase transmembrane receptor ROR1 (ROR1)
|
Antigen Info | ||||
| Payload Name |
Monomethyl auristatin E
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.